Imdur 60 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Imdur 60 mg Tablet contains isosorbide mononitrate, a nitrate vasodilator, in a prolonged-release form. Its labelling describes it for the prevention of angina (heart-related chest pain) by relaxing and widening blood vessels so blood flows more easily to the heart. It is described as not effective once an angina attack has already started, and should not be stopped suddenly.
Product Information
The following description reflects information associated with isosorbide mononitrate and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the prevention of angina (heart-related chest pain)
- Described as relaxing and widening blood vessels so blood flows more easily to the heart
- Described as not effective for an angina attack that has already begun
Described Dosage & Administration
- Taken by mouth with or without food, at a fixed time, following the doctor’s instructions or the label
- The course should be continued for as long as prescribed; stopping suddenly is described as increasing the risk of chest pain
- Lifestyle measures — diet, exercise, and avoiding alcohol and smoking — are described as recommended alongside treatment
Described Side Effects
Commonly described side effects include:
- Headache
- Dizziness
- Flushing
These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- A medical history should be shared with the doctor to avoid an inappropriate medicine combination
- The doctor should be told about any low blood pressure, kidney disease, heart failure, or raised pressure in the eye
- The doctor should be consulted about use during pregnancy or breastfeeding
- Regular monitoring of blood pressure and heart rate is described as carried out during treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains isosorbide mononitrate and is used to help prevent angina (heart-related chest pain) by relaxing and widening blood vessels. It is described as not effective for an attack that has already started. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth with or without food at a fixed time, for as long as prescribed. It should not be stopped suddenly, as this is described as increasing the risk of chest pain.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.